EGF and hepatocellular carcinoma: Overall, the variant genotypes G/G+G/A of EGF 61*A/G were associated with significantly higher HCC risk than was the A/A genotype (G/G vs. A/A, OR = 1.87, 95% CI = 1.45–2.42, P<0.001; recessive model, OR = 1.47, 95% CI = 1.26–1.71, P<0.001).